| Occluded infarct-related arteries and clinical events. | |
| | |
MedLine Citation:
|
PMID: 10871163 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Late patency of the infarct-related artery has been shown to be associated with improved long-term survival rates in observational cohort studies. However, there is a dearth of randomized trials correlating the opening of persistently occluded infarct-related arteries with clinical outcomes. Recent technological advances have improved the success and safety of percutaneous revascularization, resulting in lower restenosis and reocclusion rates. A large randomized trial is needed to evaluate clinical outcomes with percutaneous revascularization versus medical management of occluded infarct-related arteries in the absence of inducible ischemia. |
| | |
Authors:
|
M Lund; J K French; H D White |
Related Documents
:
|
11074973 - Total myocardial revascularization without cardiopulmonary bypass utilizing computer-pr... 9267353 - Left thoracotomy for reoperative revascularization of the posterior coronary circulation. 9483293 - Neurocardiology. stress and atherosclerosis. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Progress in cardiovascular diseases Volume: 42 ISSN: 0033-0620 ISO Abbreviation: Prog Cardiovasc Dis Publication Date: 2000 May-Jun |
Date Detail:
|
Created Date: 2000-07-12 Completed Date: 2000-07-12 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 0376442 Medline TA: Prog Cardiovasc Dis Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 405-18 Citation Subset: AIM; IM |
Affiliation:
|
Cardiovascular Research Unit, Green Lane Hospital, Auckland, New Zealand. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary Coronary Artery Bypass Coronary Vessels / drug effects, physiopathology*, surgery Fibrinolytic Agents / therapeutic use* Humans Myocardial Infarction / mortality, physiopathology*, therapy Myocardial Reperfusion* Recurrence / prevention & control Thrombolytic Therapy Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Early reperfusion, late reperfusion, and the open artery hypothesis: an overview.
Next Document: The open artery hypothesis: potential mechanisms of action.